ライフサイエンスコーパス: authorization

1 ries at co-payments of <or=$35 without prior authorization).

2 osteroids were identified (4 denied research authorization).

3 ard-approved waiver of consent and waiver of authorization.

4 here would be no issues with insurance prior authorization.

5 w, with waiver of informed consent and HIPAA authorization.

6 he-counter (OTC) syringe sales pending local authorization.

7 fficacy data available at the time of market authorization.

8 ew board, and patients consented to research authorization.

9 r authorization and, if so, the criteria for authorization.

10 e DMG bundle at referral, 15% at the time of authorization, 33% at 12 to 18 hours, and 45% prior to r

11 Cost and prior authorization affected the therapy choices of uveitis sp

12 A waiver of authorization and patient consent was granted by the ins

13 hether prescription of coxibs required prior authorization and, if so, the criteria for authorization

14 velopment and are refined prior to marketing authorization and, in some cases, after marketing.

15 attitudes toward financial incentives, donor authorization, and presumed consent and to identify mult

16 Financial incentives, donor authorization, and presumed consent are strategies desig

17 The authorization-based extension of Bittorrent and accompan

18 terior uveitis is affected by cost and prior authorization concerns, pregnancy considerations, and su

19 er 2006, excluding those who denied research authorization, did not have a baseline serum creatinine

20 to patients, an oversight committee, patient authorization, disclosure or prohibition of conflicts of

21 Assays that have Emergency Use Authorization (EUA) and are routinely used to detect Ebo

22 Administration (FDA) issued an Emergency Use Authorization (EUA) for intravenous peramivir, an unappr

23 to examine the agreement among emergency use authorization (EUA) tests for the detection of ZEBOV nuc

24 in the United States under an Emergency Use Authorization (EUA).

25 xpenses for initiation and maintenance of TA authorizations far exceed their related revenues and man

26 Thirty-two states required prior authorization for > or = 1 biologic DMARD, with wide var

27 positories and the standards for a waiver of authorization for disclosure and use of such data.

28 gan procurement organization, at the time of authorization for donation, 12 to 18 hours later, and pr

29 United States marketing authorization for one drug, gefitinib (an epidermal grow

30 recently demonstrated that a policy of prior authorization for prescription of nonsteroidal anti-infl

31 of the ambiguity surrounding deceased donor authorization for research, Health Insurance Portability

32 1, 1997, to December 31, 2002, who had given authorization for retrospective research were included.

33 to determine whether to grant emergency use authorization for the test, which excluded a qRT-PCR ref

34 States that implemented prior authorization for these agents initially had lower use o

35 and World Health Organization emergency use authorization for this EVD outbreak, in February 2015.

36 The study received a waiver of authorization from the institutional review board, infor

37 of Medicine in which consent was obtained or authorization given from the Orleans Parish Coroner's Of

38 ignificantly decreased from 15% in the prior-authorization group to 11% in the limited-use group (P=0

39 be attributable to the elimination of prior authorization in California during the same time frame.

40 try, then prequalified and given a marketing authorization in the user countries.

41 ncial conflicts of interest, lack of patient authorization, inappropriate access to information by th

42 Ten years after pediatric PCV7 authorization, IPD due to PCV7 serotypes had decreased b

43 Of the three initiatives, donor authorization is likely supported by more donor and nond

44 Under the Emergency Use Authorization issued in April 2009, oseltamivir can be u

45 public regarding existing and proposed donor authorization legislation and its benefits for registere

46 luding preferred drug/formulary lists, prior authorization, medication dosing/number limits, "fail-fi

47 Existing authorizations need to be kept in the market in some EU

48 systems utilizing Cerner to facilitate prior authorization of antimicrobials, prospective audit and f

49 Many dossiers submitted for the authorization of chemicals have attempted to provide the

50 r, verification of mismatch recognition, and authorization of repair.

51 ulating interest in the field and leading to authorization of the first cadre of TCIs to be marketed.

52 be accessed for research purposes (ie, with authorization or waiver of authorization, when only a li

53 A Privacy Rule's requirements for individual authorization overlap substantially.

54 cantly more favorable attitudes toward donor authorization (P<0.0001) and presumed consent (P<0.0001)

55 l infarction increased from 35% in the prior-authorization period to 88% in the limited-use period.

56 vary widely in their implementation of prior authorization policies to limit use of biologic DMARDs.

57 proportions in states with and without prior authorization policies.

58 We obtained biologic DMARD prior authorization policy information from state Medicaid pro

59 in a pharmacy-benefits program from a prior-authorization policy to a less restrictive, limited-use

60 tibiotic therapy (DOT) using preprescription authorization (PPA) vs postprescription review with feed

61 015, their high cost has led to strict prior authorization practices and high copays, and use of PSCK

62 rences in therapy choice based on cost/prior authorization, pregnancy, and subspecialty practice.

63 fore considering a revision of the marketing authorization process for antibacterial generic products

64 ation after circulatory death determination, authorization process, general contraindications to dona

65 ot influenced by the degree to which a prior-authorization program incorporated evidence-based prescr

66 The removal of a prior-authorization program led to improvement in timely acces

67 terns after the implementation of each prior-authorization program.

68 Twenty-two states implemented prior-authorization programs for coxibs during the study perio

69 stantially after the implementation of prior-authorization programs.

70 sic immunological research and for marketing authorization purposes by regulatory authorities.

71 ate Medicaid programs have implemented prior-authorization requirements before coxibs can be prescrib

72 study site was granted exemption from prior authorization requirements by radiology benefits manager

73 There were 18 states with prior authorization requirements for adalimumab or etanercept.

74 minimal additional text to also satisfy the authorization requirements under the HIPAA Privacy Rule.

75 ar to that in states that did not have prior authorization requirements.

76 me EU states, while others need complete new authorizations requiring clinical trials, quality assura

77 ant infections, in which Special Medical Use authorization restricted to patients with limited option

78 c antioxidant from rosemary with a marketing authorization, spontaneously forms a relatively stable i

79 deductibles, lower premiums, and fewer prior authorization, step therapy, and quantity limit restrict

80 In case of new authorizations, the events can easily be added to the ex

81 (DF) has received European Medicines Agency authorization to treat sinusoidal obstruction syndrome,

82 ducts have already been used under emergency authorizations to treat patients in Africa as well as pa

83 Excluding cases where donation authorization was based on prior patient documentation (

84 A waiver of authorization was granted by the institutional review bo

85 rature protocols, which were initiated after authorization was obtained for the organ to be donated a

86 oard and written informed consent with HIPAA authorization was obtained.

87 mmercial-scale CCS demonstration project and authorization was viewed as more similar to that for a p

88 Conducted under an investigational new drug authorization, we prospectively enrolled patients with n

89 Conducted under an investigational new drug authorization, we prospectively enrolled patients with n

90 ology Project facility and provided research authorization were eligible for the study.

91 herapy for each vignette when cost and prior authorization were equalized (P = .0018, P = .0049, and

92 64, and that the criteria for waived patient authorization were met.

93 urposes (ie, with authorization or waiver of authorization, when only a limited data set is evaluated

94 nstitutional review board issued a waiver of authorization, which included a waiver of informed conse